Alizapride Impurity 1 | CAS 1408441-61-1 - Request Quote
Alizapride Impurity 1
| SZ CAT No: | SZ-A210002 |
| CAS No | 1408441-61-1 |
| Mol.F. | C13H17N5O2 |
| Mol.Wt. | 275.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Alizapride Impurity 1 is chemically 5-Methoxy-N-(pyrrolidin-2-ylmethyl)-1H-benzo[d][1,2,3]triazole-6-carboxamide. Alizapride Impurity 1 is supplied with detailed characterization data compliant with regulatory guideline. Alizapride Impurity 1 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Alizapride.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1408441-61-1
Purchase 1408441-61-1
Order 1408441-61-1
Enquire 1408441-61-1
price of 1408441-61-1
1408441-61-1 Supplier
1408441-61-1 Manufacturer
1408441-61-1 Exporter
buy high quality Alizapride Impurity 1
Purchase Alizapride Impurity 1
Alizapride Impurity 1 suppliers
Alizapride Impurity 1 manufacturers
Alizapride Impurity 1 price
Order Alizapride Impurity 1
Enquire Alizapride Impurity 1
Alizapride Impurity 1 cost
Alizapride Impurity 1 Supplier
Alizapride Impurity 1 Distributor
Alizapride Impurity 1 for Method Validation
Alizapride Reference Standard
Alizapride Impurity 1 for ANDA Filing
Alizapride Impurity 1 for Forced Degradation Studies
Alizapride Impurity 1 Identification Standards
Alizapride Impurity 1 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.